Resolving the dark matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics and transcriptomics

. 2020 Jul ; 22 (7) : 1235-1246. [epub] 20200420

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid32307445

PURPOSE: Missing heritability in human diseases represents a major challenge, and this is particularly true for ABCA4-associated Stargardt disease (STGD1). We aimed to elucidate the genomic and transcriptomic variation in 1054 unsolved STGD and STGD-like probands. METHODS: Sequencing of the complete 128-kb ABCA4 gene was performed using single-molecule molecular inversion probes (smMIPs), based on a semiautomated and cost-effective method. Structural variants (SVs) were identified using relative read coverage analyses and putative splice defects were studied using in vitro assays. RESULTS: In 448 biallelic probands 14 known and 13 novel deep-intronic variants were found, resulting in pseudoexon (PE) insertions or exon elongations in 105 alleles. Intriguingly, intron 13 variants c.1938-621G>A and c.1938-514G>A resulted in dual PE insertions consisting of the same upstream, but different downstream PEs. The intron 44 variant c.6148-84A>T resulted in two PE insertions and flanking exon deletions. Eleven distinct large deletions were found, two of which contained small inverted segments. Uniparental isodisomy of chromosome 1 was identified in one proband. CONCLUSION: Deep sequencing of ABCA4 and midigene-based splice assays allowed the identification of SVs and causal deep-intronic variants in 25% of biallelic STGD1 cases, which represents a model study that can be applied to other inherited diseases.

Augenarztpraxis Dorotheenstraße Berlin Germany

Australian Inherited Retinal Disease Registry and DNA Bank Department of Medical Technology and Physics Sir Charles Gairdner Hospital Nedlands WA Australia

Bartiméus Diagnostic Center for Complex Visual Disorders Zeist The Netherlands

Center for Medical Genetics Ghent Ghent University and Ghent University Hospital Ghent Belgium

Centre de Compétence Maladie Rare Clinique Jules Verne Nantes France

Centre for Ophthalmology and Visual Science The University of Western Australia Nedlands WA Australia

CHU Lille Institut de Génétique Médicale Lille France

Department of Epidemiology Erasmus Medical Centre Rotterdam The Netherlands

Department of Genetics IIS Fundación Jiménez Díaz CIBERER Madrid Spain

Department of Histology and Embryology Medical University of Warsaw Warsaw Poland

Department of Human Genetics David Geffen School of Medicine University of California Los Angeles Los Angeles CA USA

Department of Human Genetics Radboud University Medical Center Nijmegen The Netherlands

Department of Molecular Genetics Institute of Pathology University of Ljubljana Ljubljana Slovenia

Department of Ophthalmology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

Department of Ophthalmology Amsterdam University Medical Centers Amsterdam The Netherlands

Department of Ophthalmology and Visual Sciences Universidade Federal de São Paulo São Paulo SP Brazil

Department of Ophthalmology David Geffen School of Medicine Stein Eye Institute University of California Los Angeles Los Angeles CA USA

Department of Ophthalmology Erasmus Medical Centre Rotterdam The Netherlands

Department of Ophthalmology Hadassah Medical Center Faculty of Medicine The Hebrew University of Jerusalem Jerusalem Israel

Department of Ophthalmology Leiden University Medical Center Leiden The Netherlands

Department of Ophthalmology Medical University of Warsaw SPKSO Ophthalmic University Hospital Warsaw Poland

Department of Ophthalmology New Zealand National Eye Centre Faculty of Medical and Health Sciences The University of Auckland Grafton Auckland New Zealand

Department of Ophthalmology Radboud University Medical Center Nijmegen The Netherlands

Department of Ophthalmology St Franziskus Hospital Münster Germany

Department of Ophthalmology Tel Aviv Sourasky Medical Center Tel Aviv Israel

Department of Ophthalmology The Jikei University School of Medicine Tokyo Japan

Department of Ophthalmology University Hospital University Regensburg Regensburg Germany

Department of Precision Medicine University of Campania Luigi Vanvitelli Naples and Telethon Institute of Genetics and Medicine Pozzuoli Italy

Departments of Ophthalmology and Medical Genetics University of Alberta Edmonton AB Canada

DNA Analysis Unit ŁUKASIEWICZ Research Network PORT Polish Center for Technology Development Wroclaw Poland

Donders Institute for Brain Cognition and Behaviour Radboud University Medical Center Nijmegen The Netherlands

Eye Clinic Multidisciplinary Department of Medical Surgical and Dental Sciences University of Campania Luigi Vanvitelli Naples Italy

Eye Department Greenlane Clinical Centre Auckland District Health Board Auckland New Zealand

Eye Hospital University Medical Centre Ljubljana Ljubljana Slovenia

Graduate School of Health Management Keio University Tokyo Japan

Institut des Neurosciences de Montpellier INSERM Université de Montpellier Montpellier France

Institute of Human Genetics University of Regensburg Regensburg Germany

Instituto de Genética Ocular São Paulo SP Brazil

Laboratory of Molecular and Cellular Therapy Fundacion Instituto Leloir CONICET Buenos Aires Argentina

Laboratory of Visual Physiology Division of Vision Research National Institute of Sensory Organs National Hospital Organization Tokyo Medical Center Tokyo Japan

Moorfields Eye Hospital London UK

Ophthalmic Genetics Unit OMMA Ophthalmological Institute of Athens Athens Greece

Radboud Institute for Molecular Life Sciences Radboud University Medical Center Nijmegen The Netherlands

Rare Retinal Disease Center AugenZentrum Siegburg MVZ ADTC Siegburg GmbH Siegburg Germany

Research Unit for Rare Diseases Department of Paediatrics and Adolescent Medicine 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czech Republic

RetinaScience Bonn Germany

Ruth and Bruce Rappaport Faculty of Medicine Technion Israel Institute of Technology Haifa Israel

Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

Service d'exploration de la vision et neuro ophtalmologie Centre Hospitalier Universitaire de Lille Lille France

St John of Jerusalem Eye Hospital Group East Jerusalem Palestine

The Rotterdam Eye Hospital Rotterdam The Netherlands

The Rotterdam Ophthalmic Institute Rotterdam The Netherlands

The School of Genetics and Microbiology Trinity College Dublin Dublin Ireland

UCL Institute of Ophthalmology London UK

Univ Lille Inserm CHU Lille U1172 LilNCog Lille Neuroscience and Cognition F 59000 Lille France

University Eye Hospital Hannover Medical School Hannover Germany

University of Cape Town MRC Genomic and Precision Medicine Research Unit Division of Human Genetics Department of Pathology Institute of Infectious Disease and Molecular Medicine Faculty of Health Sciences University of Cape Town Cape Town South Africa

Zobrazit více v PubMed

Carss KJ, Arno G, Erwood M, et al. Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease. Am J Hum Genet. 2017;100:75–90.

Blacharski PA, Newsome DA. Bilateral macular holes after Nd:YAG laser posterior capsulotomy. Am J Ophthalmol. 1988;105:417–418.

Cornelis SS, Bax NM, Zernant J, et al. In silico functional meta-analysis of 5,962 ABCA4 variants in 3,928 retinal dystrophy cases. Hum Mutat. 2017;38:400–408.

Sangermano R, Khan M, Cornelis SS, et al. ABCA4 midigenes reveal the full splice spectrum of all reported noncanonical splice site variants in Stargardt disease. Genome Res. 2018;28:100–110. PubMed PMC

Khan M, Cornelis SS, Khan MI, et al. Cost-effective molecular inversion probe-based ABCA4 sequencing reveals deep-intronic variants in Stargardt disease. Hum Mutat. 2019;40:1749–1759.

Schulz HL, Grassmann F, Kellner U, et al. Mutation spectrum of the ABCA4 gene in 335 Stargardt disease patients from a multicenter German cohort—impact of selected deep intronic variants and common SNPs. Invest Ophthalmol Vis Sci. 2017;58:394–403. PubMed PMC

Bauwens M, Garanto A, Sangermano R, et al. ABCA4-associated disease as a model for missing heritability in autosomal recessive disorders: novel noncoding splice, cis-regulatory, structural, and recurrent hypomorphic variants. Genet Med. 2019;21:1761–1771. PubMed PMC

Braun TA, Mullins RF, Wagner AH, et al. Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum Mol Genet. 2013;22:5136–5145. PubMed PMC

Sangermano R, Garanto A, Khan M, et al. Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides. Genet Med. 2019;21:1751–1760. PubMed PMC

Zernant J, Xie YA, Ayuso C, et al. Analysis of the ABCA4 genomic locus in Stargardt disease. Hum Mol Genet. 2014;23:6797–6806. PubMed PMC

Bauwens M, De Zaeytijd J, Weisschuh N, et al. An augmented ABCA4 screen targeting noncoding regions reveals a deep intronic founder variant in Belgian Stargardt patients. Hum Mutat. 2015;36:39–42.

Bax NM, Sangermano R, Roosing S, et al. Heterozygous deep-intronic variants and deletions in ABCA4 in persons with retinal dystrophies and one exonic ABCA4 variant. Hum Mutat. 2015;36:43–47.

Fadaie Z, Khan M, Del Pozo-Valero M, et al. Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4. Hum Mutat. 2019;40:2365–2376. PubMed PMC

Maugeri A, van Driel MA, van de Pol DJR, et al. The 2588G -> C mutation in the ABCR gene is a mild frequent founder mutation in the western European population and allows the classification of ABCR mutations in patients with Stargardt disease. Am J Hum Genet. 1999;64:1024–1035. PubMed PMC

Rivera A, White K, Stohr H, et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration. Am J Hum Genet. 2000;67:800–813. PubMed PMC

Jaakson K, Zernant J, Kulm M, et al. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene. Hum Mutat. 2003;22:395–403.

Maia-Lopes S, Aguirre-Lamban J, Castelo-Branco M, Riveiro-Alvarez R, Ayuso C, Silva ED. ABCA4 mutations in Portuguese Stargardt patients: identification of new mutations and their phenotypic analysis. Mol Vis. 2009;15:584–591. PubMed PMC

Albert S, Garanto A, Sangermano R, et al. Identification and rescue of splice defects caused by two neighboring deep-intronic ABCA4 mutations underlying Stargardt disease. Am J Hum Genet. 2018;102:517–527. PubMed PMC

Charbel Issa P, Barnard AR, Herrmann P, Washington I, MacLaren RE. Rescue of the Stargardt phenotype in Abca4 knockout mice through inhibition of vitamin A dimerization. Proc Natl Acad Sci U S A. 2015;112:8415–8420. PubMed PMC

Allocca M, Doria M, Petrillo M, et al. Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice. J Clin Invest. 2008;118:1955–1964. PubMed PMC

Lu B, Malcuit C, Wang S, et al. Long-term safety and function of RPE from human embryonic stem cells in preclinical models of macular degeneration. Stem Cells. 2009;27:2126–2135.

Cremers FPM, Cornelis SS, Runhart EH, Astuti GDN. Author response: penetrance of the ABCA4 p.Asn1868Ile allele in Stargardt disease. Invest Ophthalmol Vis Sci. 2018;59:5566–5568.

Runhart EH, Sangermano R, Cornelis SS, et al. The common ABCA4 variant p.Asn1868Ile shows nonpenetrance and variable expression of Stargardt disease when present in trans with severe variants. Invest Ophthalmol Vis Sci. 2018;59:3220–3231.

Zernant J, Lee W, Collison FT, et al. Frequent hypomorphic alleles account for a significant fraction of ABCA4 disease and distinguish it from age-related macular degeneration. J Med Genet. 2017;54:404–412. PubMed PMC

Hafez M, Hausner G. Convergent evolution of twintron-like configurations: one is never enough. RNA Biol. 2015;12:1275–1288. PubMed PMC

Zernant J, Lee W, Nagasaki T, et al. Extremely hypomorphic and severe deep intronic variants in the ABCA4 locus result in varying Stargardt disease phenotypes. Cold Spring Harb Mol Case Stud. 2018;4:a002733. PubMed PMC

Nassisi M, Mohand-Said S, Andrieu C, et al. Prevalence of ABCA4 deep-intronic variants and related phenotype in an unsolved “one-hit” cohort with Stargardt disease. Int J Mol Sci. 2019;20:5053. PubMed PMC

Runhart EH, Valkenburg D, Cornelis SS, et al. Late-onset Stargardt disease due to mild, deep-intronic ABCA4 alleles. Invest Ophthalmol Vis Sci. 2019;60:4249–4256.

Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem. 2010;79:181–211. PubMed PMC

McVey M, Lee SE. MMEJ repair of double-strand breaks (director’s cut): deleted sequences and alternative endings. Trends Genet. 2008;24:529–538. PubMed PMC

Vissers LE, Bhatt SS, Janssen IM, et al. Rare pathogenic microdeletions and tandem duplications are microhomology-mediated and stimulated by local genomic architecture. Hum Mol Genet. 2009;18:3579–3593.

Bacolla A, Wells RD. Non-B DNA conformations, genomic rearrangements, and human disease. J Biol Chem. 2004;279:47411–47414.

Fingert JH, Eliason DA, Phillips NC, Lotery AJ, Sheffield VC, Stone EM. Case of Stargardt disease caused by uniparental isodisomy. Arch Ophthalmol. 2006;124:744–745.

Riveiro-Alvarez R, Valverde D, Lorda-Sanchez I, et al. Partial paternal uniparental disomy (UPD) of chromosome 1 in a patient with Stargardt disease. Mol Vis. 2007;13:96–101. PubMed PMC

Liehr T. Cytogenetic contribution to uniparental disomy (UPD). Mol Cytogenet. 2010;3:8. PubMed PMC

Rivolta C, Berson EL, Dryja TP. Paternal uniparental heterodisomy with partial isodisomy of chromosome 1 in a patient with retinitis pigmentosa without hearing loss and a missense mutation in the Usher syndrome type II gene USH2A. Arch Ophthalmol. 2002;120:1566–1571.

Roosing S, van den Born LI, Hoyng CB, et al. Maternal uniparental isodisomy of chromosome 6 reveals a TULP1 mutation as a novel cause of cone dysfunction. Ophthalmology. 2013;120:1239–1246.

Thompson DA, Gyurus P, Fleischer LL, et al. Genetics and phenotypes of RPE65 mutations in inherited retinal degeneration. Invest Ophthalmol Vis Sci. 2000;41:4293–4299.

Thompson DA, McHenry CL, Li Y, et al. Retinal dystrophy due to paternal isodisomy for chromosome 1 or chromosome 2, with homoallelism for mutations in RPE65 or MERTK, respectively. Am J Hum Genet. 2002;70:224–229.

Wiszniewski W, Lewis RA, Lupski JR. Achromatopsia: the CNGB3 p.T383fsX mutation results from a founder effect and is responsible for the visual phenotype in the original report of uniparental disomy 14. Hum Genet. 2007;121:433–439.

Souzeau E, Thompson JA, McLaren TL, et al. Maternal uniparental isodisomy of chromosome 6 unmasks a novel variant in TULP1 in a patient with early onset retinal dystrophy. Mol Vis. 2018;24:478–484. PubMed PMC

Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535–48 e524.

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...